Common use of Confidentiality of Intellectual Property Clause in Contracts

Confidentiality of Intellectual Property. Intellectual Property shall be deemed to be the Confidential Information of the Party owning such Intellectual Property. The protection of each Party’s Confidential Information is described in Article 18. Any disclosure of information by one Party to the other under the provisions of this Article 18 shall be treated as the disclosing Party’s Confidential Information under this Agreement. It shall be the responsibility of the Party preparing a patent application to obtain the written permission of the other Party to use or disclose the other Party’s Confidential Information in the patent application before the application is filed and for other disclosures made during the prosecution of the patent application.

Appears in 7 contracts

Samples: Clinical and Commercial Manufacturing and Supply Agreement (Jazz Pharmaceuticals PLC), Master Manufacturing and Supply Agreement (Oasmia Pharmaceutical AB), Commercial Manufacturing and Supply Agreement (Oasmia Pharmaceutical AB)

AutoNDA by SimpleDocs

Confidentiality of Intellectual Property. Intellectual Property property shall be deemed to be the Confidential Information of the Party owning such Intellectual Propertyintellectual property. The protection of each Party’s Confidential Information is described in Article 18. Any disclosure of information by one Party to the other under the provisions of this Article 18 17 shall be treated as the disclosing Party’s Confidential Information under this Agreement. It shall be the responsibility of the Party preparing a patent application to obtain the written permission of the other Party to use or disclose the other Party’s Confidential Information in the patent application before the application is filed and for other disclosures made during the prosecution of the patent application.

Appears in 3 contracts

Samples: Product Development and Clinical Supply Agreement, Commercial Manufacturing and Supply Agreement (Dynavax Technologies Corp), Product Development and Clinical Supply Agreement (Genocea Biosciences, Inc.)

Confidentiality of Intellectual Property. Intellectual Property property shall be deemed to be the Confidential Information of the Party party owning such Intellectual Propertyintellectual property. The protection of each Partyparty’s Confidential Information is described in Article 18Section 9. Any disclosure of information by one Party party to the other under the provisions of this Article 18 Section 10 shall be treated as the disclosing Partyparty’s Confidential Information under this Agreement. It shall be the responsibility of the Party party preparing a patent application to obtain the written permission of the other Party party to use or disclose the other Partyparty’s Confidential Information in the patent application before the application is filed and for other disclosures made during the prosecution of the patent application.

Appears in 2 contracts

Samples: Exclusive Supply Agreement (Osmotica Pharmaceuticals PLC), Exclusive Supply Agreement (Osmotica Pharmaceuticals LTD)

Confidentiality of Intellectual Property. Intellectual Property shall be deemed to be the Confidential Information of the Party owning such Intellectual Property. The protection of each Party’s Confidential Information is described in Article 18. Any disclosure of information by one Party to the other under the provisions of this Article 18 shall be treated as the disclosing Party’s Confidential Information under this Agreement. It shall be the responsibility of the Party preparing a patent application to obtain the written permission of the other Party to use or disclose the other Party’s Confidential Information in the patent application before the application is filed and for other disclosures made during the prosecution of the patent application.. Article 18, CONFIDENTIAL INFORMATION, NONDISCLOSURE AND PUBLICITY

Appears in 1 contract

Samples: Clinical and Commercial Manufacturing and Supply Agreement

Confidentiality of Intellectual Property. Intellectual Property shall be deemed to be the Confidential Information of the Party owning such Intellectual Property. The protection of each Party’s Confidential Information is described in Article 18. Any disclosure of information by one Party to the other under the provisions of this Article 18 17 shall be treated as the disclosing Party’s Confidential Information under this Agreement. It shall be the responsibility of the Party preparing a patent application to obtain the written permission of the other Party to use or disclose the other Party’s Confidential Information in the patent application before the application is filed and for other disclosures made during the prosecution of the patent application.

Appears in 1 contract

Samples: Clinical Manufacturing and Supply Agreement (Accelerated Pharma, Inc.)

AutoNDA by SimpleDocs

Confidentiality of Intellectual Property. Intellectual Property property shall be deemed to be the Confidential Information of the Party party owning such Intellectual Propertyintellectual property. The protection of each Party’s party's Confidential Information is described in Article 18Section 8. Any disclosure of information by one Party party to the other under the provisions of this Article 18 Section 9 shall be treated as the disclosing Party’s party's Confidential Information under this Agreement. It shall be the responsibility of the Party party preparing a patent application to obtain the written permission of the other Party party to use or disclose the other Party’s party's Confidential Information in the patent application before the application is filed and for other disclosures made during the prosecution of the patent application.

Appears in 1 contract

Samples: Commercial Supply Agreement (Halozyme Therapeutics Inc)

Confidentiality of Intellectual Property. Intellectual Property shall be deemed to be the Confidential Information of the Party party owning such Intellectual Property. The protection of each Party’s party's Confidential Information is described in Article 1817. Any disclosure of information by one Party party to the other under the provisions of this Article 18 17 shall be treated as the disclosing Party’s party's Confidential Information under this Agreement. It shall be the responsibility of the Party party preparing a patent application to obtain the written permission of the other Party party to use or disclose the other Party’s party's Confidential Information in the patent application before the application is filed and for other disclosures made during the prosecution of the patent application.

Appears in 1 contract

Samples: Nerve End Cap Supply Agreement (Axogen, Inc.)

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!